Anjali Kewalramani, Shaurya Sharma, Katrina Sandejas, Daniel Rampersad, Qu Zhong, Briana Episcopia, Leon Boudourakis, John Quale
{"title":"使用初级口服万古霉素预防重症监护患者难辨梭菌感染的爆发。","authors":"Anjali Kewalramani, Shaurya Sharma, Katrina Sandejas, Daniel Rampersad, Qu Zhong, Briana Episcopia, Leon Boudourakis, John Quale","doi":"10.1017/ash.2025.10095","DOIUrl":null,"url":null,"abstract":"<p><p>Over 5.5-months, hospital-onset <i>Clostridioides difficile</i> infections (HO-CDI) in intensive care units (ICUs) increased from a baseline 6.2 cases to 19.1 cases per 10,000 patient-days (<i>P</i> = .03). Primary oral vancomycin prophylaxis (OVP) to select patients was initiated; subsequently there were 5.7 cases /10,000 patient-days (<i>P</i> = .05). Primary OVP curbed an outbreak of HO-CDI.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"5 1","pages":"e224"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451847/pdf/","citationCount":"0","resultStr":"{\"title\":\"Use of primary oral vancomycin prophylaxis to stem an outbreak of <i>Clostridioides difficile</i> infection in intensive care patients.\",\"authors\":\"Anjali Kewalramani, Shaurya Sharma, Katrina Sandejas, Daniel Rampersad, Qu Zhong, Briana Episcopia, Leon Boudourakis, John Quale\",\"doi\":\"10.1017/ash.2025.10095\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Over 5.5-months, hospital-onset <i>Clostridioides difficile</i> infections (HO-CDI) in intensive care units (ICUs) increased from a baseline 6.2 cases to 19.1 cases per 10,000 patient-days (<i>P</i> = .03). Primary oral vancomycin prophylaxis (OVP) to select patients was initiated; subsequently there were 5.7 cases /10,000 patient-days (<i>P</i> = .05). Primary OVP curbed an outbreak of HO-CDI.</p>\",\"PeriodicalId\":72246,\"journal\":{\"name\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"volume\":\"5 1\",\"pages\":\"e224\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451847/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/ash.2025.10095\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial stewardship & healthcare epidemiology : ASHE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/ash.2025.10095","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Use of primary oral vancomycin prophylaxis to stem an outbreak of Clostridioides difficile infection in intensive care patients.
Over 5.5-months, hospital-onset Clostridioides difficile infections (HO-CDI) in intensive care units (ICUs) increased from a baseline 6.2 cases to 19.1 cases per 10,000 patient-days (P = .03). Primary oral vancomycin prophylaxis (OVP) to select patients was initiated; subsequently there were 5.7 cases /10,000 patient-days (P = .05). Primary OVP curbed an outbreak of HO-CDI.